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INTRODUCTION 
Advances over the last decade in site-specific and/or 
controlled drug delivery systems are contributing to new 
and/or improved drug therapies. Drug delivery is 
becoming an increasingly important aspect in new 
product research and development in the pharmaceutical 
industry 1. Microencapsulation is one of the techniques 
used to prepare microparticles based sustained release 
formulation. The techniques of microencapsulation 
employing various polymers and their applications are 
described in standard text books. They are widely used 
techniques to achieve sustained, oral & parenteral 
controlled release products and for drug targeting 2-4 
Microspheres are one of the multi particulate drug 
delivery systems and are prepared to obtain prolonged 
(or) controlled drug delivery, to improve bioavailability 
or stability and to target drug to specific sites. 
Microspheres can be defined as solid, approximately 
spherical particles ranging from 1 to 1000μm, containing 
dispersed drug in either solution (or) microcrystalline 
form 5,6. Ethyl cellulose is non-biodegradable, bio-
compatible, non-toxic natural polymer and widely used in 
oral and topical formulation 7. The microspheres can be 
produced by several methods utilizing emulsion system 
(o/w, w/o, o/w/o and w/o/w). The common emulsion 
system used oil-in-water (o/w), with microspheres being 
produced by the emulsion solvent evaporation method. 
This relatively simple method enables the entrapment of a 
wide range of hydrophobic drugs 8. The main object of 
present study was to investigate the possibility of 
obtaining sustained release aspirin microsphere by using 
different concentration of ethyl cellulose, different 
composition of solvent mixture, different concentration of 
emulsifying agent and different stirring rate. Aspirin used 
as a model drug for the present investigation. 
Metformin HCl is a biguanide antihyperglycemic drug, 
which is orally used in the management of noninsulin-
dependent diabetes mellitus (NIDDM or Type II diabetes 
mellitus) alone or in combination with other 
hypoglycemic 9, 10. Its antihyperglycemic effect is due to 
the metabolic activities at several sites (biophase), 
including liver, intestinal muscle cells, and adipocytes 11. 
Metformin also has beneficial effect on several 
cardiovascular risk factors such as dyslipidemia, elevated 
plasma-plasminogen activator inhibitor, other fibrinolytic 
abnormalities and insulin resistance 12. It has a short 
biological half-life of 1.5–1.6 h and the daily requirement 
of it is 1.5–3 g/day 13, 14. Therefore, the marketed 
immediate release product needs to be administered 2- 3 
times daily to maintain effective plasma concentration 15. 
Henceforth, there being high incidence of gastrointestinal 
side effects and toxicity. These drawbacks can be 
overcome by designing suitable sustained release 
Metformin HCl formulations. Administration of a 
sustained Metformin HCl release dosage form could 
reduce the dosing frequency and improve the patient 
compliance. In this present study an attempt is made to 
prepare Metformin HCl ethyl cellulose micro particles by 
emulsion solvent evaporation technique using ethyl 
cellulose as a carrier to extend the period of drug release 
by retarding the release rate. The prepared microparticles 
were evaluated for drug entrapment efficiency, various 
micromeritic properties, surface morphology and in-vitro 
drug release pattern. 
MATERIALS AND METHODS 
Materials 
Metformin HCl was a gift sample from Abhilasha Pharma 
Pvt Ltd, Ankleshwar, Gujarat, India. Ethyl cellulose,EC-
1,(18–22 cps) Ethyl cellulose (40-42 cps), Sigma Aldrich 
Pvt. Ltd., USA), Span 80 (Himedia Chemicals Ltd., 
India), Dichloromethane (International Chemicals, India), 
(Merck Specialties Pvt. Ltd., India), potassium 
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dihydrogen orthophosphate (Himedia Chemicals, India), 
were used. All other chemicals were of analytical grade 
and were used as procured. 
Methods 
Preparation of microparticles 
Emulsion-solvent-evaporation technique with some 
modifications was used to prepare ethyl cellulose 
microparticles containing Metformin HCl Briefly 
Metformin HCl was dissolved in 5 ml distilled water 
ethyl cellulose was dissolved in Dichloromethane at 
various drug - polymer ratios (1:2, 1:4 and 1:6). Then 
these drug and polymer solutions were mixed and 
emulsified using a Remi Lab Magnetic stirrer (type-RQg-
128A) at 2000 rpm for about 10 min to form stable w/o 
emulsion. This stable w/o emulsion was slowly added to 
200 ml aqueous solution containing 1 % PVA and stirred 
at 800 rpm by a mechanical stirrer equipped with a three 
bladed propeller (Remi motors, India) at room 
temperature for 2 h to allow the solvent to evaporate 
completely. Microspheres were isolated by filtration and 
washed with distilled water several time to remove PVA. 
The produced microspheres were dried at ambient 
temperature (250C) for 24 h and dried in vacuum chamber 
at 250C for 2 h to remove any residual solvent. Ethyl 
cellulose microparticles containing Metformin HCl with 
their experimental formulation variables settings are 
presented in Table 1. 
   
Table1: Formulation parameters of prepared Metformin HCl-loaded ethyl cellulose microparticles. 
Formulation Polymer Drug to Polymer Ratio Stirring rate (rpm) 
F1 EC1 1:2 800 
F2 EC1 1:4 800 
F3 EC1 1:6 800 
F4 EC10 1:2 800 
F5 EC10 1:4 800 
F6 EC10 1:6 800 
 
Characterization of Microspheres     
Percentage Drug Loading 
Metformin content in the microspheres was estimated by 
UV Spectrophotometer based on the measurement of 
absorbance at 206 nm Microspheres equivalent to 100 mg 
were weighed and added in 100 ml of 0.1N HCl which was 
dissolved in a volumetric flask. The volume was made up 
to 100 ml with 0.1N of HCl. The sample was withdrawn, 
diluted suitably and measured spectrophotometrically at 
206 nm for the drug content. It was performed in 
triplicates. The percentage of drug loading in microspheres 
was estimated using the formula below: 
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Scanning electron microscopy (SEM) 
Shape and surface characteristics of the Metformin HCl-
loaded microspheres were investigated and photographed 
using scanning electron microscopy (SEM, JEOL JSM-
840A). The samples were mounted on an aluminum stage 
using adhesive carbon type and placed in a low humidity 
chamber for 12 h prior to analysis. Samples were coated 
with gold-palladium for 60 sec under an argon atmosphere 
using sputter coater in a high vacuum evaporator equipped 
with an omnirotary stage tray. Images (figure1.A and B) 
were taken at an acceleration voltage of 20 kV and 
magnifies of 33- 150. 
(A) 
 
(B) 
 
Figure 1: SEM photographs of drug loaded 
microparticles A. (EC1), B. (EC10). 
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Figure 2: SEM photographs surface of drug loaded 
microparticles. 
X-ray diffraction 
The crystalline nature of drug and drug loaded 
microparticles was  evaluated by powder XRD technique 
using  Philips model “X” Pert, diffractometer attached to 
the digital graphical assembly and a computer with Cu 
target X ray tube-4 as Cu α-radiation source in the range of  
-3˚to 136˚ of 2θ.   X-Ray powder Diffraction analysis is a 
powerful method by which X-Rays of a known wavelength 
are passed through a sample to be identified in order to 
identify the crystal structure. The wave nature of the X-
Rays means that they are diffracted by the lattice of the 
crystal to give a unique pattern of peaks of 'reflections' at 
differing angles and of different intensity, just as light can 
be diffracted by a grating of suitably spaced lines. The 
diffracted beams from atoms in successive planes cancel 
unless they are in phase, and the condition for this is given 
by the BRAGG relationship.  
nI = 2 d Sin θ 
Where, 
            l is the wavelength of the X-Rays  
           d is the distance between different plane of atoms in 
the crystal lattice.  
           θ is the angle of diffraction. 
The X-Ray detector moves around the sample and 
measures the intensity of these peaks and the position of 
these peaks [diffraction angle 2 θ]. The highest peak is 
defined as the 100% * peak and the intensity of all the 
other peaks are measured as a percentage of the 100% 
peak.
(A) 
 
(B) 
 
(C) 
 
Figure 3:  X- ray diffraction of (A) Metformin HCl (b) Ethyl cellulose (C) EC + Drug. 
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In-vitro Drug Release Studies 
The percentage of drug (Metformin HCl) released from 
ethyl cellulose microparticles were evaluated in 0.1N HCl, 
pH 1.2 and phosphate buffer, pH 6.8. The sustained release 
characteristic of these microparticles was more prominent 
in pH 6.8 than pH 1.2.The collected aliquots were filtered 
and suitably diluted to determine the absorbance using a 
UV-VIS spectrophotometer (Shimadzu, Japan) at 233nm 
for phosphate buffer, pH 6.8 and 206nm for 0.1NHCl, pH 
1.2. The release of Metformin HCl from formulations is 
shown in figure. 4 and  figure.5.  
RESULT AND DISCUSSION 
In this study, attempts have been made to develop and 
formulate Ethyl cellulose coated microspheres by solvent 
displacement technique at various drug - polymer ratios 
(1:2, 1:4 and 1:6) using two different grade of ethyl 
cellulose. Metformin HCl was used as a model drug to 
check the drug entrapment efficiency and drug release 
study. The prepared microparticles were evaluated to 
check the effect of key parameter affecting on the 
properties of microparticles. The formulations in Table 1 
were prepared in which the increasing amounts of ethyl 
cellulose either E1 or E10 types were added to the fixed 
weight of Metformin HCl with constant stirring rate.. 
Optimization and proper control of all these variables were 
essential for the formation of discrete and spherical 
microspheres. The higher the viscosity and concentration 
of the selected polymer, the more spherical in shape 
microspheres can be obtained with lesser micropores on 
the surface. The SEM micrographs and typical surface 
morphology of the microspheres is shown in Figure 2. For 
this reason, F6 microspheres prepared with the highest 
amount of ethyl cellulose E10 have more regular particles. 
Microspheres presented a narrow distribution of particle 
size and generally fallen into the 67 μm to 127 μm range. 
Type of ethyl cellulose and its added amount in 
formulations had a major effect on the viscosity, 
influencing the particle size distributions. The viscosity of 
the organic phase due to the concentration of polymer 
inside was effective on solvent diffusion and 
emulsification, while the shearing rate during stirring was 
kept constant. The geometric mean diameters of 
microspheres were found to be dependent on polymer 
concentration dispersed in the organic phase.  
XRD study of samples (Figure 3A-3C) shows that the drug 
Metformin HCl has a crystalline nature Placebo of ethyl 
cellulose amorphous nature (fig.2B). And the drug loaded 
particles shows the intermediate nature of crystalline drug 
and amorphous polymer which clearly indicates dispersion 
of drugs at molecular level in the formulation and also 
intensity of XRD was dependent on particle size and its 
distribution. XRD studies are most important tool for 
defining nature of any particles. 
There is no any interaction between Metformin HCl and 
ethyl cellulose during the evaporation process and 
microsphere formation as indicated in Table 2. The drug 
loading was affected by neither polymer content nor 
stirring rate variables, but was consistently and slightly 
lower than the theoretical loading, with high encapsulation 
efficiencies close to 100 % in all cases. Also the recovered 
amount of total microspheres demonstrated the adequacy 
of process variables during solvent evaporation. 
 
Table 2: Drug loading capacity (Metformin HCl content), encapsulation efficiency and percent yield of prepared 
Metformin HCl-loaded microspheres. 
Formulation Theoretical 
Metformin HCl 
Content a (%) 
Measured 
Metformin HCl 
Content b(%)±S.D.1 
Encapsulation 
efficiency 
(b/a x100) 
Yield (%) 
±S.D.1 
F1 33.20 31.54±1.20 95.00 80.13±0.33 
F2 33.20 31.05±0.96 93.52 88.34±0.15 
F3 27.00 25.49±0.14 94.40 86.78±0.74 
F4 27.00 25.86±0.32 95.77 86.41±0.86 
F5 22.00 21.19±0.66 96.31 92.16±0.67 
F6 22.00 21.41±0.29 97.31 80.79±0.11 
 
The ultimate aim of this present work was to develop 
sustained release drug delivery system of Metformin HCl. 
It is observed from the dissolution study that 
concentration of ethyl cellulose offers sustained effect of 
the drug up to12hrs. With increasing polymer amount and 
viscosity, the initial burst effect was significantly 
decreased in addition to the decrease in second drug 
release phase. The subsequent decreasing related to drug 
release rates can be attributed to the resulting decreased 
drug concentration gradients. In vitro drug release 
strongly depended on the type of polymer. This might be 
explained by the higher viscosity of the organic phase in 
the case of ethyl cellulose. It has been reported that the 
release of the drug depends on viscosity grade of the ethyl 
cellulose. With an increasing viscosity grade, the rate of 
release decreases. It has also been described that, in 
addition, the release rate depends on the overall viscosity 
of the system. The present study was able to confirm 
these findings; for F6 microsphere formations (1:6 drug 
to polymer ethyl cellulose E10), which had the highest 
overall viscosity, the slowest release was observed.
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Figure 4: Effect of different drug-polymer ratio (1: 2, 1: 4, and 1: 6) on the drug release of (EC1). Series1 (1:2 – 
EC1), series 2 (1:4 –EC1) and series 3 (1:6 –EC1) 
 
Figure 5: Effect of different drug-polymer ratio (1: 2, 1: 4, and 1: 6) on the drug release of (EC10). Series1 (1:2 – 
EC10), series 2 (1:4 –EC10) and series 3 (1:6 –EC10) 
CONCLUSION 
The Metformin HCl microparticles were prepared 
successfully by solvent evaporation technique. This study 
showed that during manufacture of the microspheres by 
solvent evaporation method, the viscosity and ratio of 
polymer in dispersion medium were the controlling factors 
of microsphere micromeritic parameters [16] and drug 
release. Microparticles prepared using ethyl cellulose was 
found to be spherical, discrete and free-flowing. High 
encapsulation efficiency can be attributed to the 
probability for the drug to be entrapped within the 
microparticles when increasing the amount of ethyl 
cellulose.  
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